Risk factors of recurarization after insufficient sugammadex administration: Effects of obesity and obstructive sleep apnea
Not Applicable
Recruiting
- Conditions
- patients with obesity, patients with obstructive sleep apnea, patients undergoing elective surgery
- Registration Number
- JPRN-UMIN000030263
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria were 1) patients with severe comorbidities, 2) allergies for muscle relaxants, propofol and sugammadex, 3) patients undergoing surgeries undesirable for administration of rocuronium and sugammadex, and 4) patients taking drugs that influence rocuronium and sugammadex such as antiepileptic agents, estrogen preparation, rifampicin and verapamil, 5) patients who the researcher judged inappropriate as the subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TOF ratio recovery speed
- Secondary Outcome Measures
Name Time Method Variables obtained from the neuromuscular monitoring, background variables